Clinical Trial Update: UDCA to Prevent Post-TIPS Hepatic Encephalopathy [NA]

View source ↗

Summary

A clinical trial is evaluating whether ursodeoxycholic acid can prevent hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: West China Hospital | Conditions: Hepatic Encephalopathy (HE), TIPS | NA | Status: NOT_YET_RECRUITING